Professor W. Daniel Stamer - University of Arizona

Table of Contents 

Curriculum Vitae 

Professor W. Daniel Stamer 

Contact Information….…………………..…………………………………………….….2 

Research Program Goal……..………………..………………………………...…………2 

Education………………….………………..……………………………………………..2 

Employment………………...……………………………………………………………..3 

Honors and Awards……….……..………………………………………………...……3-4 

Service………………….………..…………………..………………………………...4-10 

Outreach………………….……………………….……………………………….…….4-6 

Community Education.…..….…………………………………………4-6 

Student Mentoring Programs……….…..………………………………..6 

Citizenship………………………….….………………………………..…………..…6-10 

Department Committee Service…….……………………………………6 

Faculty Mentoring…………………….………………………………….6 

College Committee Service………………………………………………7 

Interdisciplinary Graduate Programs……………………………………..7 

University Committee Service….…………..………………………….7-8 

National Committee Service.……………………………………………..8 

Professional Affiliations………….…………………………………….8-9 

Journal Editorial Boards………………………………………………….9 

Journal Referee……………………………………………..…………….9 

Ad Hoc Grant Referee.…………..………………………………………10 

Publications/Creative Activities………..….………………………..………….…….10-15 

Refereed Journal Articles…….…………..………………….………10-14 

Refereed Reviews/Book Chapters ….………..………..……………14-15 

Editorials……...…………………………………………………………15 

Work in Progress/Manuscripts in review….…………………….………15 

Patents………….…………………………………………………..……15 

Invited Scholarly Presentations………………………………………………………16-26 

Colloquia……….…………………………………………………….16-17 

Invited Seminars….…….……………………………………………17-19 

Conference Presentations…..……..……………….…………………19-26 

Grants and Contracts………………….…..….………………………………….……26-28 

Federal Grants……….…..…………..……………………….…………26 

State Grants………….…..………………………………………………27 

Industry Grants/Contracts……….…..…………………………………..27 

Private Foundation Grants………………..……………………….….....27 

Training Grants………………………………………………………27-28 

Advanced Educational/Research Training………………………………..……..……….28 

Teaching Experience………………………………….………………………………29-32 

Undergraduate Student………………..…………………………………29 

Graduate/Medical Student………...…………………………….….……29 

Student Research Supervision………..………………….………………..………….29-30 

Dissertation/Thesis Committee Service…….…………………………………..……30-31 

Graduate Comprehensive Exam Committee Service………….....…………….…….31-32 

Graduate Students in Glaucoma Laboratory……….…………………………………….32 

Fellowship Training……………..….……………………………………………………32

Curriculum Vitae of W. Daniel Stamer Revised 2/4/2011 

Contact Information 

Office 

Laboratory 

The University of Arizona Medical Research Building 

Department of Ophthalmology 1656 East Mabel 

& Vision Science Room 230 

Medical Research Building Tucson, AZ 85724 

1656 East Mabel, Room 213 Phone: 520-626-2871 

Tucson, AZ 85724 

Phone: 520-626-7767 

Facsimile: 520-626-1757 

Email: dstamer@eyes.arizona.edu 

Research Program Goal 

The goal of the Stamer laboratory is to better understand the molecular and cellular 

mechanisms that regulate aqueous humor outflow such that novel targets can be identified 

and used for the development of therapeutics to more effectively lower intraocular pressure 

in people with glaucoma. 

Chronology of Education: 

Undergraduate 

1982-1983 University of California, Irvine 

Major: Biology 

1983-1984 University of California, Santa Cruz 

Major: Biology 

1987-1990 The University of Arizona, Tucson 

Major: Molecular and Cellular Biology 

Degree: B.S. (cum laude) 

Graduate 

1993-1996 The University of Arizona, Tucson 

College of Pharmacy 

Major: Pharmacology & Toxicology 

Minor: Physiological Sciences 

Degree: Ph.D. 

Advisor: John W. Regan, Ph.D. 

Dissertation title: Characterization of α2-adrenergic receptors 

and aquaporin-1 water channels in the human eye. 

Postgraduate 

1996 Postdoctoral Fellow, Departments of 

Pharmacology/Toxicology and Physiology 

Colleges of Pharmacy and Medicine, University of Arizona 

Major: Molecular Pharmacology/Cell Physiology 

Co-Advisors: John W. Regan, Ph.D. & Andrea Yool, Ph.D. 

1997-1998 Postdoctoral Fellow, Department of Ophthalmology 

College of Medicine, Duke University 

Major: Glaucoma/Cell Biology 

Advisor: David L. Epstein, M.D. 

2


Chronology of Employment 

1986-1989 Corneal Transplant Coordinator, Arizona Lions Eye Bank, 

Tucson, AZ. 

1989-1990 Research Assistant, Department of Pathology, The 

University of Arizona, Tucson, AZ. 

1990-1992 Research Specialist, Department of Ophthalmology, The 

University of Arizona, Tucson, AZ. 

1993-1996 Graduate Research Assistant, Pharmacology and 

Toxicology Graduate Program, The University of Arizona, 

Tucson, AZ. 

1996 Postdoctoral fellow, Departments of Physiology and 

Pharmacology/Toxicology, The University of Arizona, 

Tucson, AZ. 

1997-1998 Postdoctoral fellow, Department of Ophthalmology, Duke 

University, Durham, NC. 

1999-2003 Assistant Professor (tenure eligible), Departments of 

Ophthalmology and Pharmacology, College of Medicine, 

The University of Arizona. 

2003-present Associate Professor with Tenure, Department of 

Ophthalmology and Vision Science and Department of 

Pharmacology, College of Medicine, The University of 

Arizona 

2004-2008 Associate Head for Vision Science, College of Medicine, 

The University of Arizona. 

2008-present Professor, Department of Ophthalmology and Vision 

Science and Department of Pharmacology 

2009-present Professor, Department of Physiology 

2010 Visiting Scientist, Imperial College, London 

Honors and Awards 

1992-1993 The University of Arizona Predoctoral Fellowship, Academic 

Merit Award. 

1995-1996 Pharmaceutical Research & Manufacturers Association, 

Predoctoral Fellowship Training Award. 

1996 National Eye Institute Postdoctoral Fellowship Award for 

advanced training in vision research at Marine Biological 

Laboratory, Woods Hole. 

1997-1998 National Research Service Award #F32 EY06835, National Eye 

Institute. 

2001 Ruth Salta Junior Investigator Achievement Award, National 

Glaucoma Research, American Health Assistance Foundation. 

3


Service 

Outreach 

2001-2005 Research to Prevent Blindness, Career Development Award. 

2002 Dean’s commendation for outstanding progress on Dean’s 

Research Council Grant 

2002 “Editors selection” in International Glaucoma Review III/2, 2002. 

(Invest. Ophthalmol. Vis. Science, 2001; 42:1803-1811). 

2003 Resident Teaching Award, Basic Science Series, Department of 

Ophthalmology, 2002/3 Academic Year 

2003-pres. Member, Editorial Advisory Board, Life Sciences Journal 

2004-pres. Member, Scientific Advisory Board, American Health Assistance 

Foundation, National Glaucoma Research 

2004 Furrow Award for Excellence in Graduate Teaching, College of 

Medicine, The University of Arizona 

2005-6 Regular Member, Anterior Eye Diseases Study Section (formerly 

VIS-A), Center for Scientific Review, NIH 

2007-8 Physiology/Pharmacology Section Organizer, XVIII International 

Congress for Eye Research, Beijing, China. 

2007-pres. Member, Scientific Advisory Board, Cytokinetics Inc. 

2008 Top Reviewer in 2008, Experimental Eye Research 

2009-10 Research to Prevent Blindness Research Sabbatical Award 

2010 ARVO Fellow Service Award 

2010 Executive Editor, Experimental Eye Research 

Local/State 

Community presentations (invited) 

1. Lions MD21-A Cabinet Meeting, Lake Havasu City, AZ, 2/6/99, “Glaucoma 

Research at the University of Arizona Department of Ophthalmology”. 

2. South Side Lions, 2/23/99, “Glaucoma Research at the University of Arizona 

Department of Ophthalmology”. 

3. North Tucson Lions, 3/5/99, “Glaucoma Research at the University of 

Arizona Department of Ophthalmology”. 

4. Downtown Lions, 4/8/99, “Glaucoma Research at the University of Arizona 

Department of Ophthalmology”. 

5. Canoa Hills Community Center, 10/4/99. “Glaucoma Research at the 

University of Arizona”, Green Valley, AZ. 

6. Sight and Hearing Foundation Board Meeting, 9/19/99 (educational 

presentation about glaucoma). 

4


7. Radio Interview, News Radio Service, for Glaucoma Awareness Week, 

12/12/00. 

8. Ask AHSC, question and answer news service for rural Arizona, 3/6/01. 

9. Tucson Breakfast Lions Club, 8/15/01, Glaucoma Research at the University 

of Arizona. 

10. Canyon State Lion, “Cutting-edge research may lead to new treatments for 

glaucoma”, 9/17/01. 

11. Tucson Citizen, “Mystery protein may be key for UA glaucoma researcher”, 

11/7/01. 

12. Green Valley Community Center, 3/28/02, Finding a cure for age-related 

macular degeneration. 

13. Scottsdale Library, 4/2/02, “Finding a cure for age-related macular 

degeneration” 

14. Salpointe High School, 10/04/02, “Scientific Writing Skills”. 

15. Duval Auditorium, Arizona Health Sciences Center, 1/29/03 “Promise of 

glaucoma research”. 

16. Salpointe High School, 2/05/03, “Molecular/Cellular Biology and Glaucoma”. 

17. Salpointe High School, 10/20/04, “Molecular/Cellular Biology & Glaucoma”. 

18. Salpointe High School, 10/21/04, “Molecular/Cellular Biology & Glaucoma”. 

19. Salpointe High School, 2/7/05, “Scientific Writing/Poster Presentations”. 


21. Peoria Community Center, 4/8/05, “Research on Vision”. 

22. Arizona Lions State Convention, 5/21/05, “Breakthroughs in Eye Research”. 

23. Salpointe High School, 11/30/05, “Glaucoma Research”. 

24. Sun City Vistoso Community Center, 2/16/06, “Breakthroughs in Eye 

Research”. 


26. “Fox-11 Forum” KMSB-TV (June 11, 2006) and “In Focus” KTTU-TV (June 

18, 2006); half hour interview on Glaucoma Research. 

27. Lion’s District Governors Meeting, Mesa Arizona, “Eye Research at U of A”, 

5/18/07. 


29. Sierra Vista Low Vision Support Group, 5/29/08, “Update on Glaucoma 

Research”. 

30. Lion’s District Governor’s Meeting, “Update on Vision Research”, Prescott, 

AZ, 11/15/08. 

31. Tucson Chowder Club, “Glaucoma and Macular Degeneration”, Manning 

House, 4/29/09. 

5


32. Lion’s Multiple District Meeting, “Update on Vision Research”, Prescott, AZ, 

11/6/10. 

Student Mentoring Programs: 

1999-2002 Tucson Unified School District, Professional Internship 

Program 

1999-2007 NIH Disadvantaged Student Research Program 

1999-present Medical Student Research Program, Univ. of Arizona 

2001-present Undergraduate Biology Research Program, University of 

Arizona 

2004 Southwest Association for Education in Biomedical 

Sciences, Summer Internship Program 

Citizenship 

Intramural 

Departmental committees (Ophthalmology and Vision Science) 

1999 Member, Department of Ophthalmology Academic Review 

Committee 

2000 Member, RPB Departmental Grant Application Committee 

2000-present Chair, Research Committee 

2000-present Director, Science of Eye Disease Seminar Series 

2001-3 Member, Recruitment Committee 

2004 Chair, RPB Grant Renewal Committee 

2004-2010 Member, Promotion and Tenure Committee 

2010-present Chair, Promotion and Tenure Committee 

2004-present Member, Advisory Board 

2007 Co-chair, Self-study Committee, Academic Program 

Review 

Faculty Mentoring 

2005-2007 Tenure advisor for Lihua Marmorstein, Ph.D., Department of 

Ophthalmology and Vision Science 

2005-2006 Faculty advisor, College of Medicine Grant Seeker’s 

Program 

2006-present Tenure advisor for Roxanna Ursea, M.D., Department of 

Ophthalmology and Vision Science 

2010 Office of Faculty of Affairs Workshop: “Writing that 

Manuscript”, January 26, 2010. 

6


College Committees/Service 

1999-2007 Medical Student Interviewer 

2001-2004 Member, Committee of Nine 

2002-2005 Member, Student Progress Committee 

2002 Member, Medicine Clerkship Review Committee 

2003-2004 Member, Medical Research Building Planning Committee 

2004-2005 Member, Physiology Department Head Search Committee 

2005 Member, Self-Study Committee, Department of 

Pharmacology Academic Review 

2004-2005 Member, Steering Committee, Medical Pharmacology 

Graduate Program 

2004-2005 Member, Medical Student Committee, Institutional Self- 

Study for LCME Accreditation 

2005-2010 Elected member, Dean’s Research Council 

2005-2007 Member, Executive Committee, Medical Pharmacology 


2006-2008 Chair, Faculty Search Committee, Medical Neuroscience 

Theme 

2007-2012 Member, Dean’s Research Council, Space Committee 

2008-2011 Chair, Promotion and Tenure Committee, Department of 

Pharmacology 

2010-11 Member, Founder’s Day Award Selection Committee 

2010-pres Member, Executive Committee, Medical Pharmacology 


2010-11 Chair, Search Committee, Joint recruitment: Departments 

of Ophthalmology and Vision Science and Physiology 

Interdisciplinary Graduate Program; Faculty Affiliations 

2001-present Graduate Program in Physiological Sciences 

2001-present Graduate Program in Neuroscience 

2001-present Graduate Program in Biomedical Engineering 

1999-2004 Graduate Program in Pharmacology and Toxicology 

2004-present Graduate Program in Medical Pharmacology 

University Committees 

1999-2001 Faculty evaluator for undergraduate Upper-Division Writing 

Proficiency Examinations 

7


2001-2003 Graduate School Representative, Oral Qualifying 

Examination 

2003-2006 Member, Recruiting and Admissions Committee, 

Biomedical Engineering Graduate Program 

2002-2005 Member, Program Committee, Physiological Sciences 


2002-2004 Member, Executive Council, Pharmacology and Toxicology 


2004-2005 Member, Self-Study Committee for GIDP Biomedical 

Engineering Graduate Academic Program Review 

2005-2006 Chair, Resources Committee, Physiological Sciences 


2005-2008 Member, Executive Committee, Physiological Sciences 


2006-2007 Elected Member, Graduate Interdisciplinary Program 

Advisory Committee 

2010-2012 Chair, Resources Committee, Physiological Sciences 


2010-2012 Member, Executive Committee, Physiological Sciences 


2010-pres. Member, Executive Committee, Applied Biosciences GIDP 

Extramural 

National/International Committees 

1999-2008 Member, Congressional Liaison Committee for Public 

Policy, American Society for Cell Biology 

2004-present Member, National Research Tissue Acquisition Working 

Group, Association for Research in Vision and 

Ophthalmology 

2005-present Member, National Alliance for Eye and Vision Research 

2007-2010 Elected member, Physiology/Pharmacology Program 

Committee, Association for Research in Vision and 

Ophthalmology 

2008-present National Diabetes Research Interchange Feasibility Review 

Committee 

2010 ARVO Advocacy Day, Washington, D.C., January 29. 

Professional Affiliations/Memberships 

1990-present Association for Research in Vision and Ophthalmology 

1995-present The American Society for Cell Biology 

8


1999-present Western Pharmacology Society 

2004-present Research to Prevent Blindness Foundation 

2005-present Trabecular Meshwork Society 

2006-present International Society for Eye Research 

2006-present Association for Ocular Pharmacology and Therapeutics 

Journal Editorial Board 

2000-2002 Ad Hoc Editor, Investigative Ophthalmology and Visual 

Sciences 

2003-present Member, Editorial Advisory Board, Life Sciences Journal 

2010-present Executive Editor, Experimental Eye Research 

Journal Referee 

1997-present Investigative Ophthalmology and Visual Sciences 

2001-present Experimental Eye Research 

1999-present Archives of Ophthalmology 

2000-present American Journal of Physiology 

1999-present Life Sciences 

2001-present Current Eye Research 

2002 Brain Research 

2001 Pain 

2003-2004 Oncogene 

2003 Lasers in Surgery and Medicine 

2004 Ocular Immunology and Inflammation 

2005 Visual Neuroscience 

2005-present British Journal of Ophthalmology 

2005-present Journal of Ocular Pharmacology and Therapeutics 

2005-present Molecular Vision 

2006-present Journal of Cellular Physiology 

2006-present Journal of Glaucoma 

2006 Journal of Neuroscience 

2007 European Journal of Pharmacology 

2007 Ophthalmic Research 

2007-present British Journal of Pharmacology 

2006-present Ophthalmology 

2009 Current Molecular Medicine 

2009 PLOS Biology 

2009-present Journal of Biological Chemistry 

9


Ad Hoc Grant Referee 

2009 NIH, ETTN-E12, special emphasis panel 

2009 NIH, ETTN-E92, special emphasis panel 

2009 NIH, ETTN-E, special emphasis panel 

2009 NIH, BDCN-T, special emphasis panel 

2009 Fight for Sight Foundation 

2008 NIH, Anterior Eye Diseases study section 

2008 University of Michigan Small Grants Program 

2006 NIH, BDCN-F, special emphasis panel 

2006 National Science Foundation 

2002-5 NIH, Anterior Eye Diseases (VIS-A) study section 

2000 The University of Arizona Dean’s Research Council 

2001 Northwest Health Foundation 

2000 Robert S. Flinn Foundation 

1997 American Health Assistance Foundation 

Publications/Creative Activity (Published or Accepted) 

Refereed journal articles 

1. RW Snyder, WD Stamer, REB Seftor. (1993) Corticosteroid treatment and trabecular 

meshwork proteases in cell and organ culture supernatants. Exp. Eye. Res. 57: 461- 

468. 

2. REB Seftor, WD Stamer, EA Seftor, RW Snyder. (1994) Dexamethasone decreases 

tissue plasminogen activator activity in trabecular meshwork organ and cell cultures. 

J. Glaucoma 3:323-28. 

3. WD Stamer, RW Snyder, BL Smith, P Agre, JW Regan. (1994) Localization of 

aquaporin CHIP in the human eye: Implications in the pathogenesis of glaucoma and 

other disorders of ocular fluid balance. Invest. Ophthalmol. Vis. Sci. 35: 3867-72. 

4. WD Stamer, REB Seftor, HAM Samaha, SK Williams and RW Snyder. (1995) 

Isolation and culture of human trabecular meshwork cells by extracellular matrix 

digestion. Cur. Eye. Res.14: 611-617. 

5. WD Stamer, REB Seftor, RW Snyder and JW Regan. (1995) Cultured human 

trabecular meshwork cells express aquaporin-1 water channels. Cur. Eye. Res. 14: 

1095-1100. 

6. Y Huang, DW Gil, P Vanscheeuwijck, WD Stamer and JW Regan. (1995) 

Immunolocalization of alpha-2 adrenergic receptors in the anterior segment of the 

human eye using subtype-specific antibodies. Invest. Ophthalmol. Vis Sci. 36: 2729- 

2739. 

7. WD Stamer, Y Huang, SSP Svennson, REB Seftor, RW Snyder and JW Regan. 

(1996). Human trabecular meshwork cells express functional alpha-2A adrenergic 

receptors. Invest. Ophthalmol Vis. Sci., 37: 2426-2433. 

8. AJ Yool, WD Stamer and JW Regan. (1996) Forskolin stimulation of water and 

cation permeability in aquaporin-1 water channels. Science, 273: 1216-1218. 

10


9. WD Stamer, RW Snyder and JW Regan. (1996) Characterization of the 

transmembrane orientation of aquaporin-1 using antibodies to fusion proteins. 

Biochemistry, 35: 16313-16318. 

10. TL Anthony, KL Pierce, WD Stamer and JW Regan. (1998) Prostaglandin F2α 

receptors in the human trabecular meshwork. Invest. Ophthalmol. Vis. Sci., 39: 315- 

321. 

11. WD Stamer, BC Roberts, DN Howell and DL Epstein. (1998) Isolation, culture and 

characterization of endothelial cells from Schlemm’s canal. Invest. Ophthalmol. Vis. 

Sci. 39 1804-1812. 

12. WD Stamer, BC Roberts and DL Epstein. (1999) Hydraulic pressure stimulates 

adenosine 3’,5’-cyclic monophosphate accumulation in endothelial cells from 

Schlemm’s Canal. Invest. Ophthalmol. Vis. 40: 1983-1988. 

13. WD Stamer, BC Roberts, DL Epstein and RR Allingham. (2000) Isolation of 

trabecular meshwork cells from primary open-angle glaucomatous tissue. Curr. Eye 

Res 20: 347-350. 

14. XC Sun, KT Allen, Q Xie, WD Stamer and JA Bonanno. (2001) Effect of AQP1 

expression level on CO2 permeability in bovine corneal endothelium. Invest. 

Ophthalmol. Vis. Sci. 42: 417-423. 

15. WD Stamer, K Peppel, ME O’Donnell, BC Roberts, F Wu, and DL Epstein. (2001) 

Expression of Aquaporin-1 in human trabecular meshwork cells: Role in volume 

regulation. Invest. Ophthalmol. Vis. Sci. 42: 1803-1811. Chosen for the “Editors 

selection” in International Glaucoma Review III/2, 2002. 

16. WD Stamer, S.F. Golightly, Y. Hosohata, E. P. Ryan, E. Varga, R.J. Noecker A.C. 

Porter, C.C. Felder and H.I. Yamamura. (2001) CB1 cannabinoid receptor expression, 

activation and detection of endogenous ligand in trabecular meshwork and ciliary 

process tissues. Eur J. Pharmacol, 431: 277-286. 

17. Y Huang, WD Stamer, TL Anthony, DV Kumar, PA St. John and JW Regan. (2002) 

Expression of α2-Adrenergic Receptor Subtypes in Prenatal Rat Spinal Cord, Dev. 

Brain Res 133: 93-104. 

18. CH Mitchell, JC Fleischhauer, WD Stamer, K Peterson-Yantorno and MM. Civan. 

(2002) Human trabecular meshwork cell volume regulation, Am. J. Physiol., 283: 

C315-C326. 

19. AC Porter, SPS Svensson, WD Stamer, JJ Bahl, JG Richman and JW Regan. (2002) 

Alpha-2 adrenergic receptors stimulate actin organization in developing fetal cardiac 

myocytes. Life Sciences, 72: 1455-1466. 

20. RL Heimark, S Koachar and WD Stamer. Human Schlemm’s canal cells express the 

endothelial adherens proteins, VE-cadherin and PECAM-1 (2002). Cur. Eye Res. 25: 

299-308. 

21. AJ Yool, OH Brokl, TL Pannabecker, WH Dantzler and WD Stamer. (2002) 

Tetraethylammonium block of water flux in Aquaporin-1 channels expressed in 

11


kidney thin limbs of Henle's loop and a kidney-derived cell line, BMC Physiol, 2:4. 

(online). 

22. WD Stamer, D. Bok, Jane Hu, GJ Jaffe and BS McKay. Aquaporin-1 channels in 

human retinal pigment epithelium: Role in transepithelial water movement. (2003) 

Invest. Ophthalmol. Vis. Sci. 44: 2803-2808. 

23. JC Fleischhauer CH Mitchell, WD Stamer, MO Karl, K Peterson-Yantorno and MM. 

Civan. (2003) Common actions of adenosine receptor agonists in modulating human 

trabecular meshwork cell transport. J. Mem. Biol. 193: 121-136. 

24. SM Conley, RL Bruhn, P Morgan and WD Stamer. Selenium effects on MMP-2 and 

TIMP-1 activity in human trabecular meshwork cell supernatants. (2004). Invest. 

Ophthalmol. Vis. Sci., 45: 473-479. 

25. CR Ethier, DWH Chan, S Wada and WD Stamer. Experimental and numerical 

studies of adenoviral delivery to outflow tissues of perfused human anterior segments. 

(2004) Invest. Ophthalmol. Vis. Sci. 45:1863-1870. 

26. P Gonzalez, M Caballero, WD Stamer, PB Liton and DL Epstein. Expression 

analysis of the matrix GLA protein and VE cadherin gene promoters in the outflow 

pathway. (2004) Invest. Ophthalmol. Vis. Sci. 45: 1389-1395. 

27. AG Burke, W Zhou, BC Roberts, ET O’Brien, and WD Stamer. Effect of pressure 

gradients and Na2EDTA on transendothelial electrical resistance and hydraulic 

conductivity of Schlemm’s Canal cell monolayers. (2004) Cur. Eye Res. 28:391-398. 

28. EM Hoffman, SM Conley, WD Stamer and BS McKay. Barriers to productive 

transfection of human trabecular meshwork cells. (2005) Mol. Vision, 11:869-875. 

(online). 

29. MO Karl, JC Fleischhauer, WD Stamer, K Peterson-Yantorno, CH Mitchell, RA 

Stone, MM Civan. Differential P1-Purinergic Modulation of Human Inner-Wall 

Schlemm´s Canal Cells. (2005) Am. J. Physiol. 288:C784-C794. 

30. PB Liton, X Liu, WD Stamer, P Challa, DL Epstein and P Gonzalez. Specific 

targeting of gene expression to a subset of human trabecular meshwork cells using the 

chitinase 3-like 1 promoter. (2005) Invest. Ophthalmol. Vis. Sci. 46:183-190. 

31. KM Hardy, EA Hoffman, BS McKay and P Gonzalez, WD Stamer. Extracellular 

trafficking of myocilin in human trabecular meshwork cells. (2005) J. Biol. Chem. 

280:28917-28926. 

32. SM Conley, BS McKay, AJ Gandolfi, WD Stamer. Alterations in Human Trabecular 

Meshwork Cell Homeostasis by Selenium. (2006) Exp. Eye Res. 82: 637-647. 

33. Z Wan, L Brigatti, J. Ranger-Moore, CR Ethier and WD Stamer. Rate of change in 

central corneal thickness: A viability indicator for conventional drainage tissues in 

organ culture (2006) Exp. Eye Res. 82: 1086-1093. 

34. D Boassa, WD Stamer and AJ Yool. Ion channel function of Aquaporin-1 natively 

expressed in choroid plexus. (2006) J. Neuroscience 26: 7811-7819. 

12


35. WD Stamer, KM Perkumas, EA Hoffman, BC Roberts, DL Epstein and BS McKay. 

Coiled-coil targeting of myocilin to intracellular membranes. (2006) Exp. Eye Res. 

83:1386-1395. 

36. KM Perkumas, EM Hoffman, BS McKay, RR Allingham and WD Stamer. 

Myocilin-Associated Exosomes in Human Ocular Samples. (2007) Exp. Eye Res. 

84:209-212. 

37. WD Stamer, D Chan, CR Ethier. Targeted Gene Transfer to Schlemm’s Canal by 

Retroperfusion. (2007) Exp. Eye. Res. 84: 843-849. 

38. Z Wan, DF Woodward, C Cornell, H Fliri, J. Martos, S Petit, JW Wang, AB 

Kharlamb, LAWheeler, ME Garst, K Landsverk, CS Struble, and WD Stamer. 

Bimatoprost, Prostamide Activity and Conventional Drainage. (2007) Invest. 

Ophthalmol. Vis. Sci. 48:4107-4115. 

39. RF Ramos and WD Stamer. Effect of Cyclic Intraocular Pressure on Conventional 

Outflow Facility. (2008) Invest. Ophthalmol. Vis. Sci. 49: 275-281. 

40. VM Lopez, CL Decatur, WD Stamer, RM Lynch, BS McKay. l-DOPA is an 

Endogenous Ligand for OA1. (2008) PLOS Biology 6(9): e236. 

41. WD Stamer, DW Chan, SM Conley, SC Coons and CR Ethier. Aquaporin-1 

expression and conventional aqueous outflow in human eyes. (2008) Exp. Eye Res. 

87:349-355. 

42. R Bruhn, WD Stamer, L Herrygers, J Levine, and RJ Noecker. Relationship between 

Glaucoma and Selenium Levels in Plasma and Aqueous Humor. (2009) Br. J. 

Ophthalmol. 93:1155-1158. 

43. Y Zhang, WD Stamer, BR Davidson, JK Barton, AD. Marmorstein. Enhanced 

inflow and outflow rates despite lower IOP in Bestrophin-2 deficient mice. (2009) 

Invest. Ophthalmol. Vis. Sci. 50: 765-770. 

44. EA Hoffman, KM Perkumas, LM Highstrom and WD Stamer. Regulation of 

myocilin-associated exosome release from trabecular meshwork cells. (2009) Invest. 

Ophthalmol. Vis. Sci., 50: 1313-1318. 

45. NW Baetz, EA Hoffman, AJ Yool, WD Stamer. Role of Aquaporin-1 in Trabecular 

Meshwork Cell Homeostasis during Mechanical Strain. (2009) Exp. Eye Res. 89:95- 

100. 

46. RF Ramos GM Sumida and WD Stamer. Cyclic Mechanical Stress and Trabecular 

Meshwork Cell Contractility. (2009) Invest. Ophthalmol. Vis. Sci., 50:3826-3832. 

47. N Fatma, E Kubo, CB Toris, WD Stamer, CB Camras and DP Singh. PRDX6 

attenuates oxidative stress- and TGFβ-induced abnormalities of human trabecular 

meshwork cells. (2009) Free Radical Res. 43:783-95. 

48. AM Mortazavi, BR Simon, WD Stamer and J Vande Geest. Drained secant modulus 

for human and porcine peripapillary sclera using unconfined compression testing. 

(2009) Exp. Eye Res. 89:892-897. 

49. WD Stamer, AT Read, GM Sumida and CR Ethier. Sphingosine-1-Phosphate Effects 

on the Inner Wall of Schlemm’s Canal and Outflow Facility in Perfused Human Eyes 

(2009) Exp. Eye Res. 89:980-988. 

13


50. A Nehme, EK Lobenhofer, WD Stamer and JL Edelman. Glucocorticoids with 

different chemical structures but similar glucocorticoid receptor potency regulate 

subsets of common and unique genes in human trabecular meshwork cells. (2009) 

BMC Medical Genomics 10;2:58. 

51. KG Howell, AM Vrabel, WD Stamer and MP Fautsch. Myocilin levels in primary 

open-angle and psuedoexfoliation glaucoma aqueous humor. (2010) J. Glaucoma 

19(9): 569-575. 

52. AJ Hutchinson, SC Coons, C-L Chou, W Xu, WD Stamer, DF Woodward and JW 

Regan. Induction of Angiogenic Immediate Early Genes by Activation of FP 

Prostanoid Receptors in Cultured Human Ciliary Smooth Muscle Cells. (2010) Curr. 

Eye Res. 35:408-18. 

53. WD Stamer, D Piwnica, T Jolas, RW Carling, CL Cornell, H Fliri, J Martos, SN 

Pettit, JW Wang and DF Woodward. Cellular basis for bimatoprost effects on human 

conventional outflow. (2010) Invest. Ophthalmol. Vis. Sci. 51: 5176-5181. 

54. Y Lei, DR Overby, WD Stamer and CR Ethier. A New Method for Selection of 

Angular Aqueous Plexus Cells from Porcine Eyes: a Model for Schlemm's Canal 

Endothelium (2010) Invest. Ophthalmol. Vis. Sci. 51(11):5744-50. 

55. GM Sumida and WD Stamer. Sphingosine-1-phosphate enhances cortical 

actomyosin organization in human Schlemm’s canal endothelial cells. (2010) 

Invest. Ophthalmol. Vis. Sci. 51(12): 6633-6638. 

56. Y Lei, DR Overby, WD Stamer and CR Ethier. Outflow physiology of the mouse 

eye: Pressure dependence and ‘washout’. (2011) Invest. Ophthalmol. Vis. Sci. (in 

press). 

57. RM Pedrigi, D Simon, A Reed, WD Stamer, and DR Overby. An In Vitro Model 

of Giant Vacuole Formation (2011) Exp. Eye Res. (in press). 

58. LH Millard, DF Woodward and WD Stamer. Prostaglandin EP4 Receptor 

Activation Increases Outflow Facility in Perfused Human Eyes. (2011) Invest. 

Ophthalmol. Vis. Sci. (in press). 

59. VanderWyst SS, Perkumas KM, Read AT, Overby DR and WD Stamer. 

Structural basement membrane components and corresponding integrins in 

Schlemm's canal endothelia (2011) Mol. Vision 17:199-209. 

60. GM Sumida and WD Stamer. S1P2 Receptor Regulation of Sphingosine-1- 

Phosphate Effects on Conventional Outflow Physiology. (2011) Am J. Physiol., 

Cell Physiol. (in press). 

Refereed Review Articles/Book Chapters 

1. AJ Yool and WD Stamer. Novel roles for aquaporins as gated ion channels (2004). 

In: Advances in Molecular and Cellular Biology: Molecular and cellular insights into 

ion channel biology. Volume Editor: Robert Maue, 32: 351-379. 

2. RF Ramos, JB Hoying, MH Witte, WD Stamer, Schlemm’s canal endothelia, 

lymphatic or blood vasculature? (2007) J. Glaucoma 16: 391-405. 

14


3. WD Stamer, NW Baetz and AJ Yool. Ocular aquaporins and aqueous humor 

dynamics. The Eye’s Aqueous Humor, edition 2 in Current Topics in Membranes. 

(2008) Volume 62; Editor: MM Civan. Pages 47-70. 

4. Z Wan, DF Woodward and WD Stamer. Endogenous Bioactive Lipids and the 

Regulation of Conventional Outflow Facility. (2008) Expert Reviews in 

Ophthalmology 3:457-470. 

5. WD Stamer and RF Ramos. The Physiological Importance of Intraocular Pressure 

Oscillations in The Glaucoma Book: A Practical, Evidence-Based Approach to 

Patient Care. p52-54. P. Schacknow and J. Samples, Editors (2010). 

6. WD Stamer. The Biology of Schlemm’s Canal. In: Darlene A. Dartt, editor 

Encyclopedia of the Eye, Vol 1. Oxford: Academic Press; 2010. pp. 165-172 

7. DR Overby, WD Stamer and M Johnson. The Changing Paradigm of Outflow 

Resistance Generation: Towards Synergistic Models of the JCT and Inner Wall 

Endothelium. (2009) Exp. Eye Res. 88: 656-670. 

Editorials 

1. WD Stamer. Editors Selection: Basic Research. International Glaucoma Review 

(2004). Volume 5, Issue 3, pg. 433. 

2. WD Stamer. Editors Selection: Basic Research. International Glaucoma Review 

(2005). Volume 7, Issue 2, pg. 194. 

3 CA Curcio, AM Marmorstein, JJ Requard, P Aiken-O’Neill, WD Stamer, C 

McGahan, D Linker, J Lonsdale and L Methia. Declining availability of human eye 

tissues for research (2006). Invest. Ophthalmol. Vis. Sci. 47: 2747-2749. 

4. WD Stamer. Editors Selection: Basic Research. International Glaucoma Review 9-1, 

pg. 14 (2007). 

Work in Progress 

Manuscripts in preparation/review 

1. NW Baetz, WD Stamer and AJ Yool. Stimulation of aquaporin-1 mediated fluid 

transport by cyclic GMP in human retinal pigment epithelium in vitro (in review). 

2. WD Stamer, EA Hoffman, JM Luther, DL Hachey and KL Schey. Protein Profile 

of Exosomes from Trabecular Meshwork Cells (in review). 

3. KM Perkumas and WD Stamer. Molecular markers for cultured Schlemm’s canal 

endothelial cells (in preparation). 

4. WD Stamer, Y Lei, A Boussommier-Calleja, DR Overby, and CR Ethier. 

Elevated Conventional Outflow Facility of eNOS Transgenic Mice (in 

preparation). 

Patents 

1. United States Patent #7803558, “Modulation of Aqueous Humor Outflow by 

Targeting Cadherin-5 between Schlemm’s Canal Cells”; University of Arizona 

15


reference number: UA03-036. Licensed by Advanced Glaucoma Technologies, 

Inc. 4/4/06. Patented issued 9/28/10. 

Invited Scholarly Presentations 

Colloquia 

1. “Aquaporin-1 and aqueous humor outflow”. XXXII Ophthalmic Biochemistry 

Conference, Oakland University, Detroit, Michigan, November, 1997. 

2. “Subcellular localization of myocilin”. Genetics and Molecular Biology Catalyst 

Meeting. Glaucoma Research Foundation. San Juan, Puerto Rico, December, 1998. 

3. “Fluid flow stimulates adensosine 3’,5’-cyclic monophosphate accumulation in 

endothelial cells from Schlemm’s canal”. Abstract#431, XIII International Congress 

of Eye Research, Paris, France July, 1998. 

4. “Glaucoma is associated with defects in the secretory pathway”. Role of 

TIGR/Myocilin in glaucoma catalyst meeting, Glaucoma Research Foundation, 

Oakland, California, April, 2000. 

5. “Conceptos Actuales de Investigacion en Glaucoma”. Colegio de Oftalmologos del 

Estado de Sonora Conference. Nogales, Sonora, Mexico, September, 2000. 

6. “Aquaporin-1: Role in resting cell volume”. Abstract #598. XIV International 

Congress of Eye Research, Santa Fe, New Mexico, October, 2000. 

7. “Myocilin: evidence for a vesicle tether”. Tucson Traffic Jam Symposium, Tucson, 

Arizona, July, 2001. 

8. “Aspectos Moleculares y Nuevos Desarrollos en Ciencias Basicas”, Coloquio de 

Glaucoma, Hermosillo, Sonora, Mexico. December 2001. 

9. “Selective inhibition by tetraethylammonium of water not ion fluxes in aquaporin-1 

channels”. Miami, FL, Transport 2002. 

10. “Inner wall of Schlemm’s canal and outflow resistance”, XIV International Congress 

of Eye Research, Geneva, Switzerland, October 2002. 

11. “Adherens junction in Schlemm’s canal: a novel target for glaucoma therapy”, IV 

International Glaucoma Symposium, Barcelona, Spain, March 2003. 

12. “Role for cannabinoids in aqueous humor dynamics”, Lipid Mediator Special Interest 

Group Session, Association for Research in Vision and Ophthalmology, Ft. 

Lauderdale, FL, May 2003. 

13. “Targeting of myocilin to nascent intercellular junctions”. XV International Congress 

of Eye Research, Sydney, Australia, August 2004. 

14. “Role of Aquaporin-1 in movement of water out of the eye”, Ocular aquaporins: A 

tour through the eye, Association for Research in Vision and Ophthalmology, Ft. 

Lauderdale, FL, May 2005. 

16


15. “Coiled-coil Targeting of Myocilin to Intracellular Membranes”, Trabecular 

Meshwork Society Meeting, San Francisco, CA, December, 2005. 

16. “Contribution of Outflow Cells to Pathology”, Second Annual ARVO/Pfizer 

Ophthalmic Research Institute Conference. “Aqueous Humor Outflow: What do we 

know? Where will it lead us?” April 28-9 2006, Ft. Lauderdale, FL. Session 

Moderator. 

17. “Dynamic regulation of outflow resistance by cell-cell adhesions”, XVI International 

Congress of Eye Research, Buenos Aires, Argentina, Oct. 29- Nov. 3, 2006. 

18. “Targeted gene transfer to Schlemm’s canal by retroperfusion in organ culture”, 

Trabecular Meshwork Society Meeting, San Diego, CA, December, 2006. 

19. “VE-cadherin, a therapeutic target for ocular hypertension”, Association for Ocular 

Pharmacology and Therapeutics, 8 th Scientific Meeting, San Diego, CA, February 9- 

11, 2007. 

20. “Cyclic intraocular pressure oscillations decrease outflow facility and increase 

cellularity of human anterior segments in organ culture”, Trabecular Meshwork 

Society Meeting, Washington, D.C., December, 2007. 

21. “Aquaporin-1 and aqueous humor dynamics”, West Coast Salt and Water Club, 

Morro Bay, CA, March 8, 2008. 

22. “Anterior Segment Perfusion Special Interest Group”, Session Organizer/Moderator, 

Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, May 

2008. 

23. “S1P and Human Conventional Outflow”, XVII International Congress of Eye 

Research, Beijing, China, Sept. 24-29, 2008. 

24. “Role of Cytoskeletal Dynamics and Intercellular Junctions in S1P-Mediated Effects 

on Human Outflow Facility”. Association for Research in Vision and Ophthalmology, 

Ft. Lauderdale, FL, May 2009. 

25. “Targeting Conventional Outflow: Where’s the resistance?” 

Organizer/Moderator/Speaker. Association for Research in Vision and 

Ophthalmology, Ft. Lauderdale, FL, May 2010. 

26. “Cellular Basis for Outflow Regulation” XIX International Congress of Eye 

Research, Montreal, Canada, July, 2010. 

Invited Seminars 

1. Modeling of the human aqueous humor outflow Pathway”, Allergan Pharmaceuticals, 

Irvine, CA, September, 1999. 

2. “Myocilin and cellular secretion”, Graduate Student Seminar Series in Pharmacology 

and Toxicology, Tucson, AZ, January, 2000. 

3. “Myocilin and cellular secretion”. Alcon Pharmaceuticals, Ft. Worth, TX, February, 

2000. 

17


4. “Molecular Physiology of Aqueous Humor Outflow”, The University of Arizona, 

Physiological Sciences Graduate Program Seminar Series, Tucson, August, 2001. 

5. “Molecular Physiology of Aqueous humor outflow”, Human Physiology Program, 

University of California at Davis, March, 2001. 

6. “Cadherin regulation of aqueous humor outflow”, Dean’s Research Council Brown 

Bag Seminar, May, 2002. 

7. “Human eye tissue usage in glaucoma research”, Workshop on ophthalmic research 

tissue acquisition, Anaheim, CA, Nov. 2003. 

8. “Regulation of Aqueous Humor Outflow”, Biomedical Engineering Graduate 

Program Seminar Series, The University of Arizona, November 2004. 

9. “The genetics of glaucoma: Role of myocilin”, Frontiers in Research Seminar Series, 

College of Medicine, The University of Arizona, November, 2005. 

10. “Drug targets in glaucoma”, Medicinal Chemistry Graduate Program Seminar Series, 

College of Pharmacy, The University of Arizona, January 2006. 

11. “Neurodegenerative diseases of the eye”, Frontiers in Research Seminar Series, 

College of Medicine, The University of Arizona, April, 2006. 

12. “Aquaporin-1 and Aqueous Humor Dynamics”, Science of Disease Seminar Series, 

presented with Nobel Laureate, Dr. Peter Agre, Duke University Eye Center, May 

2006. 

13. “Myocilin and glaucoma”, Research Group Seminar, Duke University Eye Center, 

May 2006. 

14. “Myocilin-associated exosomes and glaucoma”, University of Regensburg, 

Regensburg, Germany. July 28, 2006. 

15. “ Effect of cyclic biomechanical stress on fluid flow through the conventional 

drainage tissues”. 5 th World Congress of Biomechanics, Munich, Germany, 

August 2006. 

16. “Myocillin, exosomes and glaucoma”, Vanderbilt Eye Institute 2006-7 

Academic Seminar Series, Nashville, TN, October, 2006. 

17. “Therapeutically targeting the conventional outflow pathway; Bimatoprost and 

beyond”, Allergan Pharmaceuticals, Irvine, CA, February 16 th , 2007. 

18. “Glaucoma, Conventional Drainage and Myocilin-Associated Exosomes”, 

Storm Eye Institute, Medical University of South Carolina, April 9 th , 2007. 

19. “Effect of S1P on human conventional Drainage”, Allergan Pharmaceuticals, 

Irvine, CA, June 19, 2007. 

20. “Modeling and targeting human conventional outflow”, Pfizer Pharmaceuticals, 

San Diego, CA, October 15, 2007. 

21. “AQP1 and aqueous humor dynamics: Water movement across the RPE”, 

Epithelial Biology Group, The University of Arizona, 2/28/08. 

18


22. “Mechanical and pharmacological regulation of human conventional outflow”, 

Visual Science Seminar Series, University of North Texas Health Sciences 

Center, Ft. Worth, TX, 8/20/08. 

23. “In Vitro and In Situ Laboratory Models of Conventional Drainage”, Allergan, 

Inc., Irvine, CA, 8/29/08. 

24. “Cellular basis for cyclic mechanical stress-induced regulation of outflow 

facility”, Symposium Glaucoma 2009; basic and clinical aspects. Erlangen, 

Germany, March 6-7, 2009. 

25. “Physiological models of human conventional outflow”, Department of 

Physiology Research Picnic, The University of Arizona, 6/12/09. 

26. “Mechanical and Pharmacological regulation of conventional outflow of 

aqueous humor”, July 21, 2009, Institute for Developmental Research, Aichi 

Human Service Center, Nagoya, Japan. 

27. “Paracrine and Mechanical Regulators of Human Conventional Outflow 

Facility”, Frontiers in Vision Science Seminar Series, Bascom Palmer Eye 

Institute, Miami, FL, 9/24/09. 

28. “Cellular Basis for Bimatoprost Effects on Human Conventional Drainage”, 

Trabecular Meshwork Society Meeting, San Diego, CA, 12/5/09. 

29. “Advances in Aqueous Humor Outflow: Engineering Approaches and New Strategies 

to Lower IOP”. Institute of Ophthalmology, University College of London, London, 

UK. March 16, 2010. 

30. “Mechanical and Pharmacological Regulation of Conventional Outflow”. Storm Eye 

Institute. Medical College of South Carolina, April 29, 2010. 

31. “Role of Bioactive Lipids in Human Conventional Outflow Function”. The 

University of Regensburg, Germany, June 25, 2010. 

32. “Monitoring dynamic physiology of conventional outflow”. Department of 

Physiology, University of Pennsylvania, October 21, 2010. 

33. “eNOS-Mediated Enhancement of Outflow Facility in Transgenic Mouse Eyes” 

Trabecular Meshwork Society Meeting, Philadelphia, PA, 12/11/10. 

34. “Use of Transgenic Mice to Unravel Outflow Function”, Duke University Eye 

Center, Durham, NC, 12/17/10. 

35. “Physiological Models for Glaucoma Research”, Fudan University Eye Hospital, 

Shanghai, China, 1/17/11. 

36. “Physiological Models to Assess Glaucoma Therapeutics”, Asia ARVO, Singapore, 

1/21/11. 

Conference Presentations 

1. WD Stamer, JC Jahnke, MC McDermott and RW Snyder. Effect of Ciprofloxacin on rabbit 

corneal endothelial viability. Invest. Ophthalmol. Vis. Sci., ARVO abstracts #1936, 1991. 

2. RW Snyder, WD Stamer, SA Limstrom, JC Jahnke and J Hunts. Corticosteroid 

treatment regulates trabecular meshwork fibrinolytic enzymes. Invest. Ophthalmol. 

Vis. Sci., ARVO abstracts #2136, 1992. 

19


3. RW Snyder, WD Stamer, EA Seftor, TR Kramer and REB Seftor. Dexamethasone 

regulates tissue plasminogen activator in trabecular meshwork organ and cell 

cultures. Invest. Ophthalmol. Vis. Sci., ARVO abstracts #2155, 1993. 

4. TR Kramer, B Matsumoto, I Hale, RW Snyder, RJ Noecker and WD Stamer. Laser 

Scanning Confocal immunofluorescence Microscopy of the Extracellular Mateix 

Compnents of the Human Trabecular Meshwork: A Three Dimensional Study. 

Invest. Ophthalmol. Vis. Sci., ARVO abstracts #3826, 1994. 

5. Y. Huang, P. Vanscheeuwijck, WD Stamer and JW Regan. Immunohistochemical 

Localization of Alpha-2 Adrenergic Receptors in the Anterior Segment of the Human 

Eye with Subtype-Specific Antibodies. Invest. Ophthalmol. Vis. Sci., ARVO 

abstracts # 2949, 1994. 

6. WD Stamer, RW Snyder, BL Smith, P Agre and JW Regan. Localization of 

Aquaporin CHIP in the Human Eye. Invest. Ophthalmol. Vis. Sci., ARVO abstracts # 

924, 1994. 

7. REB Seftor, WD Stamer, HAM Samaha, SK Williams and RW Snyder. Human 

trabecular meshwork cell isolation and subsequent culturing using an extracellular 

matrix digestion technique. Invest. Ophthalmol. Vis. Sci., ARVO abstracts # 2216, 

1995. 

8. WD Stamer, Y Huang, REB Seftor, RW Snyder and JW Regan. Human trabecular 

meshwork cells express functional alpha-2A adrenergic receptors. Invest. 

Ophthalmol. Vis. Sci., ARVO abstracts #2292, 1995. 

9. WD Stamer, RP Gruener, TH Burkey and JW Regan. Activation of the human α2A, 

α 2B and α 2C adrenergic receptor subtypes stimulates MAP kinase activity in COS 

cells. Society for Neuroscience, abstract # 08920, 1995. 

10. WD Stamer, RW Snyder and JW Regan. Antibodies to recombinant fusion proteins 

confirm the molecular orientation of loops C and E, and the carboxyl terminus of 

aquaporin-1. The American Society for Cell Biology, abstract # 321, 1995. 

11. WD Stamer, RW Snyder TH Burkey and JW Regan. Activation of 2A-Adrenergic 

receptors in human trabecular meshwork cells stimulates MAP kinase activity. 

Invest. Ophthalmol. Vis Sci., ARVO abstract #952, 1996. 

12. JW Regan, WD Stamer and Y Huang. α2-Adrenergic receptors subtypes: Molecular 

biology and localization in ocular tissue. XII International Congress on Eye 

Research, abstract # 260, 1996. 

13. JW Regan, WD Stamer and AJ Yool. Water channels and receptors: Potential 

interactions affection the regulation of cellular water permeability. XII International 

Congress on Eye Research, abstract # 261, 1996. 

14. SPS Svensson, AC Porter, WD Stamer, JJ Bahl and JW Regan. α2-adrenergic 

receptors stimulate actin organization in developing fetal cardiac myocytes. The 

American Society for Cell Biology, 1996. 

15. WD Stamer, JW Regan and AJ Yool. Calcium influences water and cation fluxes in 

Xenopus oocytes expressing aquaporin-1. The American Society for Cell Biology, 

1996. 

20


16. WD Stamer BC Roberts, DL Epstein and BS McKay. Myocilin functions in vesicle 

formation and fusion. Am. Soc. Cell Biol., Abstract #1195, 1998, (submitted). 

17. BC Roberts, WD Stamer and DL Epstein. Isolation and culture of endothelial cells 

from Schlemm’s canal. Invest. Ophthalmol. Vis Sci ARVO abstract#2246, 1998. 

18. DL Epstein, BS McKay, BC Roberts, T Borras and WD Stamer. Native and 

recombinant TIGR/MYOC localizes to vesicles. Invest. Ophthalmol. Vis Sci ARVO 

abstract #2247, 1998. 

19. WD Stamer, BS McKay BC Roberts, T Borras and DL Epstein. Myosin-like domain 

of TIGR/MYOC targets to vesicles. Invest. Ophthalmol. Vis Sci ARVO abstract 

#2021, 1998. 

20. BS McKay, BC Roberts and WD Stamer. Myocilin functions in cell-cell junction 

formation. Am. Soc. Cell Biol., Abstract #2373, 1999. 

21. WD Stamer, K Peppel, ME O’Donnell, BC Roberts, F Wu, and DL Epstein. 

Aquaporin-1 regulates resting volume in human trabecular meshwork cells. Invest. 

Ophthalmol. Vis Sci ARVO abstract #2660 1999. 

22. SF Golightly, RJ Noecker, HI Yamamura, WD Stamer. CB1 Receptors and Aqueous 

Humor Dynamics. Western Pharmacological Society. Abstract #T23, 2000. 

23. WD Stamer, RR Allingham, BC Roberts and BS McKay Subcellular localization of 

myocilin mutants. Invest. Ophthalmol. Vis Sci ARVO abstract #2792, 2000. 

24. BS McKay, BC Roberts, WD Stamer. Myocilin Functions in Nascent Cell Junction 

Formation. Invest. Ophthalmol. Vis Sci ARVO abstract #4482, 2000. 

25. S.F. Golightly, E. P. Ryan, H.I. Yamamura, R.J. Noecker and W.D. Stamer. 

Cannabinoid receptors and aqueous humor dynamics. Invest. Ophthalmol. Vis Sci 

ARVO abstract #1318, 2000. 

26. WD Stamer, Y Hosohata, EP Ryan, E Varga, HI Yamamura. Cannabinoids interact 

with functional CB1 receptors in primary cells from ciliary process and trabecular 

meshwork. Invest. Ophthalmol. Vis Sci ARVO abstract #3981, 2001. 

27. A Burke, EP Ryan, N Atodaria, BC Roberts and WD Stamer. Relationship between 

hydraulic conductivity and transendothelial electrical resistance of Schlemm’s canal 

cell monolayers Invest. Ophthalmol. Vis Sci ARVO abstract #4478, 2001. 

28. BS McKay, HP Erickson and WD Stamer. Myocilin: a vesicle tether in retina and 

RPE. Invest. Ophthalmol. Vis Sci ARVO abstract #1041, 2001. 

29. BS McKay, WD Stamer and HP Erickson. Myocilin is a VAMP-Associated protein. 

Am. Soc. Cell Biol., Abstract #605, 2000. 

30. EP Ryan, TS Haley, RL Heimark and WD Stamer. Vascular endothelial cadherin 

expression in human Schlemm’s canal cells. Invest. Ophthalmol. Vis Sci, ARVO 

abstract #4097, 2002. 

31. EA Hoffman, EP Ryan, BS McKay and WD Stamer. Biochemical analysis of native 

and recombinant myocilin in human trabecular meshwork cells and supernatants. 

Invest. Ophthalmol. Vis Sci, ARVO abstract #1055, 2002. 

21


32. WD Stamer, GJ Jaffe and BS McKay. Expression of aquaporin-1 in human retinal 

pigment epithelium. Invest. Ophthalmol. Vis Sci, ARVO abstract #4571, 2002. 

33. JC Fleischhauer, CH Mitchell, WD Stamer, K Peterson-Yatorno, and MM Civan. 

Human trabecular meshwork cell volume regulation. Invest. Ophthalmol. Vis Sci, 


34. WD Stamer, Y Hosohata, EP Ryan, AC Porter, E Varga, CC Felder and HI 

Yamamura. Cannabinoid CB1 receptor activation and detection of endogenous ligand 

in eye tissues. Western Pharmacology Society/XXV Congreso Nacional de 

Farmacologia, abstract #WE-49, 2002. 

35. RL Bruhn, SM Conley, P Morgan and WD Stamer. Selenium effects on 

metalloproteinase activity in human trabecular meshwork cell supernatants. 


36. WD Stamer, DWH Chan, AT Read and CR Ethier. Efficiency of adenoviral gene 

transfer to outflow cells in perfused human anterior segments. Invest. Ophthalmol. 

Vis Sci, ARVO abstract #1180, 2003. 

37. P Gonzalez, PB Liton, M Caballero, WD Stamer, X Liu, MG Bodman and DL 

Epstein. Search for promoters to target gene expression in selected cells of the 

outflow pathway. Invest. Ophthalmol. Vis Sci, ARVO abstract #1141, 2003. 

38. MO Karl, JC Fleischhauer, WD Stamer, K Peterson-Yatorno, CH Mitchell, RA 

Stone and MM Civan. Cells acutely harvested from inner-wall cells and explantderived 

cells from inner- and outer-wall of Schlemm’s canal display functional 

adenosine receptors. Invest. Ophthalmol. Vis Sci, ARVO abstract #3462, 2003. 

39. KM Hardy, EA Hoffman, BS McKay, and WD Stamer. Myocilin Association 

with Exosome-Like Vesicles in Human Trabecular Meshwork Cells. Am. Soc. 

Cell Biol., Abstract #1298, 2003. 

40. SM Conley, BS McKay and WD Stamer, Selenium Effects on Integrin Activity 

and Intracellular Signaling in Trabecular Meshwork cells, Invest. Ophthalmol. Vis 

Sci, ARVO abstract #4416, 2004. 

41. WD Stamer, DJ Rak and BS McKay, Coiled-coil interactions of native myocilin, 


42. EM Hoffman, A Poncius, BS McKay and WD Stamer, Cell Cycle 

Synchronization and Transfection Efficiency of Human Trabecular Meshwork 

Cells, Invest. Ophthalmol. Vis Sci, ARVO abstract #4432, 2004. 

43. Z. Wan, N. Atodaria, RJ. Noecker and WD Stamer, Bimatoprost Effects on 

Hydraulic Conductivity of Outflow Cell Monolayers, Invest. Ophthalmol. Vis Sci, 


44. KM Hardy, EA Hoffman, BS McKay and WD Stamer, Biochemical Properties 

of Extracellular Myocilin, Invest. Ophthalmol. Vis Sci, ARVO abstract #3664, 

2004. 

45. MO Karl, JC Fleishhauer, WD Stamer, K Peterson-Yatorno, CH Mitchell, RA 

Stone and MM Civan. Schlemm’s Canal cells and trabecular meshwork cells as 

potential targets in IOP modulation. Invest. Ophthalmol. Vis Sci, ARVO abstract 

#416, 2004. 

22


46. PB Liton, P Challa, X Lui, M Caballerao, WD Stamer and DL Epstein. 

Specific targeting of gene expression to a subset of human trabecular meshwork 

cells using the Chitinase-3-like-1 promoter in adenoviral –mediated gene 

transfer experiments. Invest. Ophthalmol. Vis Sci, ARVO abstract #4368, 2004. 

47. MA Hauser, D Layfield, J Yang, T Wang, E Hoffman, WD Stamer and R 

Allingham. SAGE expression analysis of trabecular meshwork to identify 

POAG susceptibility genes. Invest. Ophthalmol. Vis Sci, ARVO abstract #1097, 

2005. 

48. SM Conley and WD Stamer. Selenium toxicity in trabecular meshwork cells. 


49. EA Hoffman, SM Conley, BS McKay and WD Stamer. Role of DNase I in 

transfection efficiency of human trabecular meshwork cells. Invest. Ophthalmol. 


50. Z. Wan, WD Stamer and L Brigatti. Ultrasound pachymetry and viability of 

anterior segment perfusion model. Invest. Ophthalmol. Vis Sci, ARVO abstract 

#3665, 2005. 

51. RF Ramos and WD Stamer. Introduction of two physiological factors to 

anterior segment perfusion model. Invest. Ophthalmol. Vis Sci, ARVO abstract 

#3673, 2005. 

52. WD Stamer, DW Chan and CR Ethier. Targeted viral delivery to Schlemm’s 

canal by retroperfusion in organ culture. Invest. Ophthalmol. Vis Sci, ARVO 

abstract #220, 2006. 

53. RF Ramos and WD Stamer. Effect of pulsatile pressure on outflow facility of 

human anterior segments in organ culture. Invest. Ophthalmol. Vis Sci, ARVO 

abstract #224, 2006. 

54. SM Conely, Z Wan, S Coons and WD Stamer. Functional alterations in the 

trabecular meshwork after selenium treatment. Invest. Ophthalmol. Vis Sci, 


55. KM Perkumas, EA Hoffman, Z Wan, RR Allingham, MP Fautsch and WD 

Stamer. Myocilin-associated exosomes in human samples. Invest. Ophthalmol. 


56. Z Wan, DF Woodward and WD Stamer. Bimatoprost effects on conventional 

drainage tissues. Invest. Ophthalmol. Vis Sci, ARVO abstract #3919, 2007. 

57. SC Coons, Z Wan, DF Woodward and WD Stamer. Bimatoprost and 

AGN211334 effects on hydraulic conductivity of trabecular monolayers. Invest. 

Ophthalmol. Vis Sci, ARVO abstract #3923, 2007. 

58. EA Hoffman, KM Perkumas, KM Hardy and WD Stamer. Regulation of 

myocilin-associated exosomes from trabecular meshwork cells. Invest. 


59. RF Ramos and WD Stamer. Effects of cyclic intraocular pressure oscillations 

on tissue viability of human anterior segments in organ culture. Invest. 


23


60. GM Sumida, AT Read, KM Perkumas, WD Stamer and CR Ethier. S1P 

receptor mediated effects on outflow facility of human eyes in organ culture. 


61. SB Zanello, A Perry, WD Stamer and R Heimark. Regulation of junctional 

proteins in Schlemm’s canal cells. Invest. Ophthalmol. Vis Sci, ARVO abstract 

#5908, 2007. 

62. AJ Hutchinson, SC Coons, WD Stamer and JW Regan. Novel Signaling 

Pathways Regulated by Prostanoid Receptors in Human Ciliary Smooth Muscle 

Cells. The American Society for Cell Biology. Abstract # 1384, 2007. 

63. AT Read, WD Stamer and CR Ethier. S1P Effects on Morphology of Outflow 

Pathway in Human Eyes. Invest. Ophthalmol. Vis Sci, ARVO abstract #1634, 

2008. 

64. KM Perkumas, SB Zanello, RL Heimark, WD Stamer. VEGF Receptor 1 and 2 

in Human Schlemm’s Canal Cells Invest. Ophthalmol. Vis Sci, ARVO abstract 

#683, 2008. 

65. EA Hoffman, N Baetz and WD Stamer. Stretch-Induced Aquaporin-1 Expression 

in Human Trabecular Meshwork Cells. Invest. Ophthalmol. Vis Sci, ARVO 

abstract #680, 2008. 

66. RF Ramos and WD Stamer. Cyclic Mechanical Stress and Trabecular Meshwork 

Cell Contractility. Invest. Ophthalmol. Vis Sci, ARVO abstract #679, 2008. 

67. N Baetz, AJ Yool and WD Stamer. Atrial Natriuretic Peptide and Fluid Transport 

Across Human Retinal Pigment Epithelium. Invest. Ophthalmol. Vis Sci, ARVO 

abstract #5553, 2008. 

68. GM Sumida and WD Stamer. S1P Receptor-Mediated Effects in Human 

Schlemm’s Canal Endothelial Cells. Invest. Ophthalmol. Vis Sci, ARVO abstract 

# 682, 2008. 

69. AJ Hutchinson, SC Coons, WD Stamer, DF Woodward and JW Regan. Novel 

Signaling Pathways Regulated by Prostanoid Receptors in Human Ciliary Smooth 

Muscle Cells. Invest. Ophthalmol. Vis Sci, ARVO abstract #2619, 2008. 

70. NW Baetz, WD Stamer and AJ Yool. Atrial Natriuretic Peptide and Retinal 

Pigment Epithelium Fluid Movement. Am. Soc. Cell Biol., Abstract #1353, 2008. 

71. David F. Woodward, Jenny W. Wang, Thierry Jolas, David Piwnica, Robert W. 

Carling, Clive L. Cornell, Hans Fliri, Jose Martos, Simon N. Pettit, W. Daniel 

Stamer. Evidence For A Bimatoprost-Sensitive Prostamide Receptor In Human 

Ocular Cells Associated With Conventional Outflow. 4 th International 

Conference on Phospolipase-A2 and Lipid Mediators. Tokyo, Japan March 25-28, 

2009. 

72. GM Sumida and WD Stamer. S1P activation of Rho/ROCK pathway in human 

Schlemm’s canal endothelial cells in culture. Invest. Ophthalmol. Vis Sci, ARVO 

abstract #807, 2009. 

73. LM Highstrom, DF Woodward and WD Stamer. Characterization of 

prostaglandin EP4 receptors in human conventional outflow cells. Invest. 


24


74. SS VanderWyst and WD Stamer. Structural Basement Membrane Components 

and Corresponding Integrins in Human Schlemm’s Canal Endothelia. Invest. 


75. M Johnson, EH Zhou, R Krishnan, K Perkumas, WD Stamer, CR Ethier and J 

Fredberg. Stiffness of Schlemm’s Canal Cells in vitro and in vivo. Invest. 


76. JL Edelman, A Nehme, E Lobenhofer and WD Stamer. Dexamethasone, 

Fluocinolone Acetonide and Triamcinolone Acetonide Generate Unique Patterns 

of Gene Expression in Human Trabecular Meshwork Cells. Invest. Ophthalmol. 


77. WD Stamer, T Jolas, D Piwnica, RW Carling, CL Cornell, H. Fliri, J Martos, SN 

Pettit, J Wang, DF Woodward. Evidence for bimatoprost-sensitive prostamide 

receptors in human ocular cells associated with aqueous humor outflow. 

Abstract#127, 11 th International Conference on Bioactive Lipids, Cancun, 

Mexico, October 25-28, 2009. 

78. GM Sumida and WD Stamer. “Sphingosine-1-phosphate promotion of 

circumferential MLC phosphorylation in human Schlemm’s canal endothelial 

cells.” Abstract #128, 2009, 11 th International Conference on Bioactive Lipids, 

Cancun, Mexico, October 25-28, 2009. 

79. EH Zhou, WD Stamer, R Krishnan, K Perkumas, CR Ethier, JJ Fredberg, M 

Johnson. Mechanical characterization of Schlemm's canal endothelial cells in 

vitro. Am. Soc. Cell Biol., December 5-9, Abstract #140, 2009. 

80. LH Millard, DF Woodward and WD Stamer. Prostaglandin EP4 Receptor 

Activation Increases Outflow Facility in Perfused Human Eyes. Invest. 


81. GM Sumida, WD Stamer. Sphingosine-1-Phosphate Receptor Antagonist 

Increases Outflow Facility. Invest. Ophthalmol. Vis Sci, ARVO abstract #152, 

2010. 

82. SS VanderWyst, AT Read, DR Overby, WD Stamer. Patterned Expression of 

LM-511 and Integrin α6 in Human Schlemm’s Canal Endothelia. Invest. 


83. KM Perkumas, SS VanderWyst, RL Heimark, WD Stamer. Markers That 

Differentiate Human Schlemm’s Canal From Trabecular Meshwork Cells in 

Culture. Invest. Ophthalmol. Vis Sci, ARVO abstract #154, 2010. 

84. EA Hoffman, KL Schey, WD Stamer. Protein Expression Pattern of Trabecular 

Meshwork Cell Exosomes. Invest. Ophthalmol. Vis Sci, ARVO abstract #155, 

2010. 

85. R Vargas-Pinto, K Perkumas, WD Stamer, D Ho, M Johnson. Young’s Modulus 

of Schlemm’s Canal Cells Using Atomic Force Microscopy. Invest. Ophthalmol. 

Vis Sci, ARVO abstract #2131, 2010 

86. DF Woodward, JW Wang, D Piwnica, T Jolas, RW Carling, CL Cornell, H Fliri, J 

Martos, SN Pettit, WD Stamer. Rapid Characterization of Bimatoprost 

Pharmacology in Human Ocular Cells by Using Cellular Dielectric Spectroscopy. 


25


87. RD McCarty, RM Beverley, MC Giovingo, MJ Nolan, BYJT. Yue, WD Stamer, 

PA Knepper. Differential Pattern of Junctional Complex Lipid Raft Proteins in 

Human Conventional Outflow. Invest. Ophthalmol. Vis Sci, ARVO abstract 

#3204, 2010. 

88. GM Sumida and WD Stamer. S1P1 receptor activation is insufficient to mimic 

S1P-mediated effects on aqueous humor. FASEB, abstract #1640, 2010. 

89. WD Stamer, D Piwnica and DF Woodward. Bioactive lipids modulate 

contractility of ocular outflow cells. Keystone Symposia Conference. Bioactive 

lipids: Biochemistry and Disease. Kyoto, Japan, June 6-11. 

90. EH Zhou, R Krishnan, WD Stamer, KM Perkumas, K Rajendran, JJ Fredberg 

and M Johnson. . Stiffness and Traction Forces of Schlemm's Canal Endothelial 

Cells in Vitro. Abstract# 817. XIX International Congress of Eye Research, 

Montreal, Canada, July, 2010. 

91. LH Millard, K Watanabe, A Shimada, DF Woodward and WD Stamer. 

Prostaglandin/Prostamide F Synthase Expression in Human Eyes. Abstract #500. 

XIX International Congress of Eye Research, Montreal, Canada, July, 2010. 

Grants and Contracts: 

Federal Grants 

2009-2014 Co-Principal Investigator, Bioengineering Research Program Grant 

(Administrative PI: Mark Johnson). National Eye Institute, R01 EY19696, 

“The Mechanical Basis of Primary Open-Angle Glaucoma”. 

2009-2014 Co-Investigator, (Civan, PI), National Eye Institute, R01 EY013624, 

“Aqueous Humor Outflow Control and Intraocular Pressure”. 

2006-2012 Principal Investigator, National Eye Institute, R01 EY17007, “Cadherin 

Dynamics and Glaucoma”. 

2001-2011 Principal Investigator, National Eye Institute, R01 EY12797, “Molecular 

Mechanisms of Myocilin Function in the Human Eye”. 

2003-2006 Principal Investigator, National Eye Institute, R03 EY15115 “Seleniuminduced 

Glaucoma”. 

2008 Principal Investigator, National Institute for General Medical Sciences, 

R01 GM59986, “Regulation of Ion Channel Function of Aquaporin-1”. 

2003-2007 Co-Principal Investigator, (AJ Yool, Co-P.I.) National Institute for 

General Medical Sciences, R01 GM59986, “Regulation of Ion Channel 

Function of Aquaporin-1”. 

2002-2005 Principal Investigator, National Eye Institute, R03 EY13861, “Cadherin 

Regulation of Aqueous Humor Outflow”. 

26


State Grants 

2000-2001 25% Effort, Principal Investigator, Dean’s Research Council (DRCG), 

“Fluid Flow Routes across Schlemm’s Canal”; Received Dean’s 

commendation for outstanding progress 2/20/02. 

Private Industry Grants/Contracts 

2000 Unrestricted Research Grant, Allergan, Inc. 





2006 Research Contract, Pfizer Pharmaceuticals 


2007 Research Contract, Pfizer Pharmaceuticals 

2007 Research Contract, Allergan, Inc. 


2008 Research Contract, Allergan, Inc. 



2010 Research Contract, GlaxoSmithKline 

Private Foundation Grants 

2010 Principal Investigator, Research to Prevent Blindness Foundation, 

Research Sabbatical Award. 

2001-2003 25% Effort, Principal Investigator, American Health Assistance 

Foundation (AHAF), G2001-026, National Glaucoma Research Award, 

“Role of Aquaporin-1 in the Permeability of Schlemm’s Canal”. 

1999-2000 25% Effort, Principal Investigator, Glaucoma Research Foundation 

(GRF), “Effect of mutations in myocilin on cellular secretion”. 

1998-1999 25% Effort, Co-Principal Investigator, American Health Assistance 

Foundation (AHAF), National Glaucoma Research Award, “Role of 

TIGR/MYOC Protein in Human TM Cells”. 

Training Grants 

2006-2008 Thesis mentor for Renata Ramos, National Eye Institute, F31-EY16887, 

“Biomechanical factors that regulate outflow facility”. 

27


2006-2011 Faculty, NIH Cardiovascular Training Grant, T32 HL007955 (P.I.: 

Barton). 

2007-2012 Faculty, Graduate Training in Systems and Integrative Physiology, T32- 

GM08400 (P.I.: Hoyer). 

2007-2012 Faculty, Interdisciplinary Training in Cardiovascular Research, T32- 

HL07249 (P.I.: Burt). 

Advanced Educational/Research Training 

Problem-based Learning Facilitation Workshop 

William R. Galey, Ph.D. 

University of New Mexico School of Medicine 

October, 1999 

Grantsmanship Seminar/Workshop for Biomedical Research Scientists 

Presented by Federation of American Societies for Experimental Biology 

Instructors: Stephen W. Russell, D.V.M., Ph.D. and David Morrison, Ph.D. 

June, 2001 

Research Mentoring Workshop 

Douglas L. Weed, M.D., PhD., M.P.H. 

National Cancer Institute 

Presented by Arizona Cancer Prevention and Control Training Program 

February, 2002 

Anterior Segment Perfusion Training 

C. Ross Ethier, Ph.D. 

The University of Toronto 

June, 2003 

Neuroscience Facilitators’ Training Workshop 

College of Medicine, The University of Arizona 

Jill Keller, Ph.D., Office of Educational Development 

August, 2003 

Interactive Lecture Workshop 

College of Medicine, The University of Arizona 

Steve Wright, Ph.D. 

February, 2006 

Research Sabbatical 

Department of Bioengineering 

Imperial College, London 

C. Ross Ethier, Ph.D. 

January-July, 2010 

28


Teaching Experience 

Undergraduate Teaching 

Term Course Lecture 

Hours 

Spring 99 PCOL 436/536, Chemotherapy of Infectious 

Disease 

Spring 01-04 BME 411/511, Physiology for Biomedical 

Engineering 

Fall 01-02 BME 410/510, Biology for Biomedical 

Engineering 

Graduate/Medical Student Teaching 

Avg. # of 

Students 

5 120 

5 30 

4 25 

Spring 02 PCOL 421, Pharmacy Case Discussions 4.5 12 

Fall 04 BME 495/595c, Current Topics in BME 1 30 

Term Course Lecture/ 

Discussion 

Hours 

Avg. # of 

Students 

Spring 99-03 MED 801X, Integrated Problem-based learning 12 8 

Fall 99-09 PCOL 551, Molecular Pharmacology 6 16 

Fall 99-09 PCOL 602a, Systems Toxicology 1.5 25 

Fall 99- 

present 

PCOL 501/801, Medical Pharmacology Case Studies 

(Now CPR block) 

6 12 

Spring 01-05 PCOL 653, Neuropharmacology 3 14 

Fall 02- 

present 

PHCL 595b, Scientific Writing Strategies, Skills and 

Ethics, Course Coordinator 

24 30 

Fall 03 MED 825, Medical Neuroscience Case Studies 15 8 

Spring/Fall 04-09 

PHCL 595c, Critical Literature Review and Seminar 7 40 

Fall 05-08 PCOL 630b, Cell Signaling 3 20 

2006-present ArizonaMed, Neuroscience Block 8 110 

2006-09 ArizonaMed, Neuroscience Block, CBI 27 8 

Student Research Supervision 

Year Student Name Academic Level Program of Study 

1999-2000 Shawna Golightly Undergraduate School Undergraduate Independent Study 

2000 Salma Koachar High School NIH Disadvantaged Student Research Program 

2000 Aimee Worthen High School TUSD Professional Internship Program 

2000 Edward Kim Undergraduate School Federal Work/Study Program 

2000 Bo Yang Graduate School Laboratory Rotation/PharmTox 

2000 Jason Levine Medical School Ophthalmology Elective/Lab rotation 

2001 Helen Smith High School 

29 

TUSD Profession Internship Program


2000-1 Andrew Burke Graduate School Research year before medical school 

2001 Lisa Lane Medical School Ophthalmology Elective/Lab rotation 

2001 Melba Jaramillo High School NIH Disadvantaged Student Research Program 

2001 Theodore Haley Medical School Medical Student Research Program 

2001 Kyler Hunter Graduate School Laboratory Rotation/PharmTox 

2001 Sambhitab Salvi Graduate School Laboratory Rotation/PharmTox 

2001-2 Lisa Herrygers, M.D. Residency Resident Research Project 

2001-2 John Alberdi Graduate School Laboratory Rotation/BME 

2001-2 Dawn Nice Graduate School Laboratory Rotation/Psio 

2001 Parham Morgan Medical School Ophthalmology Elective/Lab rotation 

2001-2 Kevan Bayne High School TUSD Profession Internship Program 

2002-3 Kathy Hardy Graduate School Gerontological Studies Graduate Program 

2002-3 Roberta Bruhm Graduate School Epidemiology Graduate Program 

2002-3 Neil Atodaria, M.D. Residency Resident Research Project 

2002 Andrew Burke Medical School Summer Research Project 

2002 Dustin Marshall High School NIH Disadvantaged Student Research Program 

2002 Andrew Lietag Graduate School Laboratory Rotation 

2002-3 Salma Koachar Undergraduate School Undergraduate Biology Research Program 

2003 Parham Morgan, MD Fellow Ophthalmology Residency 

2003-7 Zhou Wan Graduate School Medical Pharmacology Graduate Program 

2003 Alexandra Poncius Undergraduate School Undergraduate Biology Research Program 

2003-4 Tasnuva Kaochar High School NIH Disadvantaged Student Research Program 

2002-5 Shannon Conely Graduate School Pharmacology/Toxicology Graduate Program 

2003-8 Renata Ramos Graduate School Biomedical Engineering Graduate Program 

2004 Chane Rains Graduate School Laboratory Rotation/PharmTox 

2004 Snow Slade Medical School Medical Student Research Program 

2004 Greg Martin Graduate School Laboratory Rotation/BME 

2004-5 Chieko Saito Graduate School Laboratory Rotation/Physiological Sciences 

2005 Jennifer Morris Undergraduate School Senior Thesis 

2005-8 Nicholas Baetz Graduate School Cell Biology/Anatomy Graduate Program 

2006 Ashley Blum Undergraduate School Research Internship 

2006-10 Grant Sumida Graduate School Physiological Sciences Graduate Program 

2007 Brianna Paisley Graduate School Laboratory Rotation/Medical Pharmacology 

2007 Lindsey Highstrom Graduate School Laboratory Rotation/Medical Pharmacology 

2007 Edward DeHoog Graduate School Independent Study/BME 

2007 Saumya Vanderwist Graduate School Laboratory Rotation/BME 

2008 Phat Tran Graduate School Laboratory Rotation/BME 

2008-9 Jenny Zhu Undergraduate School Undergraduate Biology Research Program 

2008 Joseph Keyes Graduate School Laboratory Rotation/BME 

2008-9 Tucker Carrocci Undergraduate School Independent Study 

2008 Aimen Kasasbeh Graduate School Laboratory Rotation/Neuroscience 

2009 Deepika Laddu Graduate School Laboratory Rotation/Medical Pharmacology 

2009 Chandra Khatri Graduate School Laboratory Rotation/BME 

2009 Joanne Durn Graduate School Visiting student, Bradford University, UK 

2009-pres Joseph Catallini Undergraduate School Volunteer/Work Study 

2010 Shannon Niere Undergraduate School Independent study 

2010-pres Michael Weinand Undergraduate School Independent study 

2010 Kevin Osarski Graduate School Laboratory Rotation/BME 

2010-pres Nicole Ashpole Graduate School Laboratory Rotation/BME 

2010 Chris Fronczek Graduate School Laboratory Rotation/BME 

Graduate Thesis/Dissertation Committee Service (*primary advisor) 

Years of 

Service 

Student Name Graduate Program Current Status 

1999-2001 Kenneth Witt Pharmacology/Toxicology Graduated with Ph.D 

1999-2002 Dinesh Srinivasan Pharmacology/Toxicology Graduated with Ph.D 

30


1999-2004 Daniela Boassa Neuroscience Graduated with Ph.D. 

2000-2003 Bo Yang Pharmacology/Toxicology Graduated with Ph.D. 

2001-2004 Zachary Derbyshire Pharmacology/Toxicology Graduated with Ph.D. 

2000-2003 Rebecca Mulholland Pharmacology/Toxicology Graduated with Ph.D. 

2001-2003 Lynne Martin Pharmacology/Toxicology Graduated with M.S. 

2001-2003 Catherine Dumitrov Pharmacology/Toxicology Graduated with M.S. 

2002-2006 Sharon Hom Physiological Sciences Graduated with Ph.D. 

2002-2004 Karen Sandoval Pharmacology/Toxicology Graduated with Ph.D. 

2002-2004 Mohab Ibrahim Pharmacology/Toxicology Graduated with Ph.D. 

2002-2005 Dawn Birdsell Physiological Sciences Graduated with Ph.D. 

2003-2006 Robert Kuester Pharmacology/Toxicology Graduated with Ph.D. 

2002-2003 *Kathy Hardy Gerontology Graduated with M.S. 

2002-2005 *Shannon Conley Pharmacology/Toxicology Graduated with Ph.D. 

2002-2008 Roberta Bruhn Epidemiology Graduated with Ph.D. 

2003-2007 *Zhou Wan Medical Pharmacology Graduated with Ph.D. 

2003-pres Wei Xu Pharmacology/Toxicology Graduated with Ph.D. 

2002-2006 Elton Migliati Physiological Sciences Graduated with Ph.D. 

2003-2006 Cortnie Short Physiological Sciences Graduated with Ph.D. 

2003-2006 Katherine Horak Pharmacology/Toxicology Graduated with Ph.D. 

2004-2006 Jennifer Uno Physiological Sciences Graduated with Ph.D. 

2004 Hope Dang Applied Biosciences Graduated with M.S. 

2004-2008 *Renata Ramos Biomedical Engineering Graduated with Ph.D. 

2004-2008 Katherine Hardy Cell Biology and Anatomy Graduated with Ph.D. 

2004-2007 Melissa Brym Pharmacology/Toxicology Graduated with Ph.D. 

2004-2007 Edita Navratolova Medical Pharmacology Graduated with Ph.D. 

2005 Matt McReynolds Physiological Sciences Graduated with M.S. 

2005-2008 Daveline Israel Pharmacology and Toxicology Graduated with Ph.D. 

2005-2009 Chris Campos Medical Pharmacology Graduated with Ph.D. 

2005-2007 Tyson Kinnick Physiological Sciences Graduated with Ph.D. 

2005-2009 *Nicholas Baetz Cell Biology and Anatomy Graduated with Ph.D. 

2005 Samira Najmaii Medical Pharmacology Graduated with M.S. 

2005-2008 Margaret Keck Physiological Sciences Graduated with Ph.D. 

2006-2010 *Grant Sumida Physiological Sciences Graduated with Ph.D. 

2007-2009 Yaofeng Cheng Medical Pharmacology Graduated with Ph.D. 

2007-2008 Marcos Teran Physiological Sciences Graduated with M.S. 

2007-2008 Stacy Dunaway Medical Pharmacology Graduated with M.S. 

2007-2010 *Lindsey Highstrom Medical Pharmacology Graduated with Ph.D. 

2007-2009 Justin Kowell Medical Pharmacology Graduated with M.S. 

2007-pres *Saumya VanderWyst Biomedical Engineering Medical Leave 

2008 Ariane Mortazavi Aerospace and Mechanical Engineering Graduated with M.S. 

2008-2010 Evisabel Craig Pharmacology and Toxicology Graduated with Ph.D. 

2009-pres Weixi Kong Medical Pharmacology 

2009-pres Lucy Sanchez-Covarrubias Medical Pharmacology 

2009-pres Jin Yan Medical Pharmacology 

2009-pres David Aguilar Medical Pharmacology 

2009 Brianna Paisley Medical Pharmacology Graduated with M.S. 

2010 Gabriel Orsinger Biomedical Engineering Graduated with M.S. 

2010-pres *Nicole Ashpole Biomedical Engineering 

2011-pres Dipti Tillu Medical Pharmacology 

2011-pres Xiaomei Wei Medical Pharmacology 

BME Comprehensive Exam Committee Service 

Year of Exam Student Name 

2005 Cody Bliss 

2005 Kristen O’Halloran 

2006 Renata Ramos 

31


2006 Tim Troutman 

2006 Alex Tumulinson 

2006 Greg Martin 

2006 (retake) Tim Troutman 

Graduate Students/Stamer Laboratory 

Graduated Student’s Name Current Position 

2003 (M.S.) Kathy Hardy, Ph.D. Postdoctoral Fellow, Children’s Memorial Research 

Center, Chicago, IL 

2005 Shannon Conley, Ph.D. Postdoctoral Fellow, Oklahoma State University 

2007 Zhou Wan, M.D., Ph.D. Private practice, Houston, TX. 

2008 Renata Ramos, Ph.D. Postdoctoral Fellow, Rice University, Houston, TX 

2009 Nicholas Baetz, Ph.D. Postdoctoral Fellow, Vanderbilt University, Nashville, TN 

2010 Grant Sumida, Ph.D. Postdoctoral Fellow, UC Davis, Davis, CA 

2010 Lindsey Millard, Ph.D. 

Fellowship Training in Stamer Laboratory 

Years in 

training 

Fellow’s Name Current Position 

2001 Neil Atodaria, M.D. Private Practice, Phoenix, AZ 

2006-2007 Suzanne Zanello, Ph.D. NASA, Houston, TX. 

2006-2007 Elton Migliati, D.V.M., Ph.D. Oregon Health Sciences University, OR 

2010-present W. Michael Dismuke, Ph.D. 

32

Professor W. Daniel Stamer - University of Arizona

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?